Victory Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Victory Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-81,460	Closed	-$1.22M	–	2524
2025 Q2	$1.22M	Hold	81,460	–	–	﹤0.01%	1753
2025 Q1	$1.07M	Hold	81,460	–	–	﹤0.01%	1766
2024 Q4	$1.29M	Hold	81,460	–	–	﹤0.01%	1676
2024 Q3	$1.29M	Sell	81,460 -1,295	-2%	-$20.8K	﹤0.01%	1674
2024 Q2	$1.26M	Sell	82,755 -2,860	-3%	-$41K	﹤0.01%	1600
2024 Q1	$1.26M	Hold	85,615	–	–	﹤0.01%	1630
2023 Q4	$1.19M	Sell	85,615 -6,825	-7%	-$91.2K	﹤0.01%	1628
2023 Q3	$1.24M	Hold	92,440	–	–	﹤0.01%	1550
2023 Q2	$1.17M	Sell	92,440 -16,770	-15%	-$196K	﹤0.01%	1585
2023 Q1	$1.24M	Buy	+109,210	New	+$1.18M	﹤0.01%	1584
2019 Q4	–	Sell	-254,610	Closed	-$1.93M	–	3135
2019 Q3	$1.93M	Buy	+254,610	New	+$1.89M	﹤0.01%	1477

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management's RDY Position: Q3 2025 in Review

Victory Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 81,460 shares — an estimated $1.22M sold.

Victory Capital Management first reported a position in RDY in Q3 2019 and held it in 11 quarters. The position peaked at $1.93M in Q3 2019. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

Victory Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
Victory Capital Management sold 81,460 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $1.22M.
Victory Capital Management first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 11 quarters.
Victory Capital Management's Dr. Reddy's Laboratories position peaked at $1.93M in Q3 2019.
228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.